IL188848A - Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions
- Google Patents
Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions
Info
Publication number
IL188848A
IL188848AIL188848AIL18884808AIL188848AIL 188848 AIL188848 AIL 188848AIL 188848 AIL188848 AIL 188848AIL 18884808 AIL18884808 AIL 18884808AIL 188848 AIL188848 AIL 188848A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2006/002016external-prioritypatent/WO2007010383A1/en
Application filed by Mochida Pharm Co LtdfiledCriticalMochida Pharm Co Ltd
Publication of IL188848A0publicationCriticalpatent/IL188848A0/en
Publication of IL188848ApublicationCriticalpatent/IL188848A/en
IL188848A2005-07-222008-01-17Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions
IL188848A
(en)
Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions
Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions